ES2482441A1 - Use of L-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars - Google Patents

Use of L-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars Download PDF

Info

Publication number
ES2482441A1
ES2482441A1 ES201201199A ES201201199A ES2482441A1 ES 2482441 A1 ES2482441 A1 ES 2482441A1 ES 201201199 A ES201201199 A ES 201201199A ES 201201199 A ES201201199 A ES 201201199A ES 2482441 A1 ES2482441 A1 ES 2482441A1
Authority
ES
Spain
Prior art keywords
carnitine
scars
treatment
cosmetic products
stretch marks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201201199A
Other languages
Spanish (es)
Other versions
ES2482441B1 (en
Inventor
María Rosa JIMÉNEZ-CASTELLANOS BALLESTEROS
María Jesús LUCERO MUÑOZ
Marta CASAS DELGADO
Carmen VÁZQUEZ CUETO
Alfonso Mate Barrero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Sevilla
Original Assignee
Universidad de Sevilla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Sevilla filed Critical Universidad de Sevilla
Priority to ES201201199A priority Critical patent/ES2482441B1/en
Priority to PCT/ES2013/000258 priority patent/WO2014080051A1/en
Publication of ES2482441A1 publication Critical patent/ES2482441A1/en
Application granted granted Critical
Publication of ES2482441B1 publication Critical patent/ES2482441B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Abstract

The invention relates to the use of L-carnitine or its salts and derivatives in dermatological cosmetic products, preferably within the technical field associated with the cosmetic treatment of all types of superficial scars and stretch marks on mammals, preferably humans, as a result of the antifibrotic effect of carnitine.

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen4image4

imagen7image7

imagen8image8

imagen9image9

imagen4image4

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

imagen16image16

imagen17image17

imagen18image18

imagen19image19

imagen20image20

imagen21image21

imagen22image22

imagen23image23

imagen24image24

imagen25image25

imagen26image26

imagen27image27

imagen28image28

imagen25image25

imagen29image29

imagen30image30

imagen31image31

imagen25image25

imagen32image32

imagen33image33

imagen25image25

imagen34image34

imagen35image35

imagen36image36

imagen25image25

imagen37image37

imagen38image38

imagen39image39

imagen25image25

imagen40image40

imagen41image41

imagen42image42

imagen43image43

imagen44image44

imagen45image45

Claims (1)

imagen1image 1 imagen2image2 imagen3image3 imagen4image4
ES201201199A 2012-11-20 2012-11-20 Use of L-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars Active ES2482441B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201201199A ES2482441B1 (en) 2012-11-20 2012-11-20 Use of L-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars
PCT/ES2013/000258 WO2014080051A1 (en) 2012-11-20 2013-11-20 Use of l-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201201199A ES2482441B1 (en) 2012-11-20 2012-11-20 Use of L-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars

Publications (2)

Publication Number Publication Date
ES2482441A1 true ES2482441A1 (en) 2014-08-01
ES2482441B1 ES2482441B1 (en) 2015-03-31

Family

ID=50775578

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201201199A Active ES2482441B1 (en) 2012-11-20 2012-11-20 Use of L-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars

Country Status (2)

Country Link
ES (1) ES2482441B1 (en)
WO (1) WO2014080051A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2251126T3 (en) * 1998-02-19 2006-04-16 Beiersdorf Aktiengesellschaft COSMETIC OR DERMATOLOGICAL COMPOSITION THAT CONSISTS OF CARNITINE AND / OR AN ACILCARNITINE AND AT LEAST AN ANTIOXIDANTS.
WO2007043339A1 (en) * 2005-09-30 2007-04-19 Showa Denko K.K. Carnitine derivative, salt thereof, external skin preparation and cosmetic material
US20080206290A1 (en) * 2007-02-26 2008-08-28 Beiersdorf Ag Cosmetic combination product for improving appearance
US20120089105A1 (en) * 2005-05-13 2012-04-12 Beiersdorf Ag Self-adhesive skin patch and combination set for cosmetic skin care

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2251126T3 (en) * 1998-02-19 2006-04-16 Beiersdorf Aktiengesellschaft COSMETIC OR DERMATOLOGICAL COMPOSITION THAT CONSISTS OF CARNITINE AND / OR AN ACILCARNITINE AND AT LEAST AN ANTIOXIDANTS.
US20120089105A1 (en) * 2005-05-13 2012-04-12 Beiersdorf Ag Self-adhesive skin patch and combination set for cosmetic skin care
WO2007043339A1 (en) * 2005-09-30 2007-04-19 Showa Denko K.K. Carnitine derivative, salt thereof, external skin preparation and cosmetic material
US20080206290A1 (en) * 2007-02-26 2008-08-28 Beiersdorf Ag Cosmetic combination product for improving appearance

Also Published As

Publication number Publication date
ES2482441B1 (en) 2015-03-31
WO2014080051A1 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
GT201500011A (en) 5-AMINOTETRAHYDROQUINOLIN-2-NEW CARBOXYLIC ACIDS AND THEIR USE
CU20140082A7 (en) PYRIMIDINES AND FUSIONATED TRIAZINS REPLACED AND THEIR USE
BR112014001050A2 (en) polyamide block copolymer, method for preparing the same, composition, controlled release and personal care products, and method for preparing a gel composition
UY33863A (en) METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BR112015011679A2 (en) portable pad
BR112015005369A2 (en) usp30 inhibitors and methods for their use
CO2019008103A2 (en) Pharmaceutical compositions for combination therapy
ES2596248T3 (en) N-Carbamoylputrescine to improve muscle protein synthesis
CL2015002692A1 (en) Novel benzenesulfonamide compounds, method to synthesize them and use of the compounds in medicine and cosmetics.
CY1122640T1 (en) TREATMENT AND PREVENTION OF RADIATION DERMATITIS
BR112016001919A2 (en) cosmetic composition and cosmetic treatment process
ES2711427T8 (en) Lactobacillus reuteri ATCC PTA 6475 for use in the prevention or treatment of bone loss in mammals
BR112014000795A2 (en) Cosmetic and / or dermatological use of oligosaccharide compounds in the prevention and treatment of stretch marks.
BR112014011481A2 (en) collagen hydrolyzate and its use
BR112015024703A2 (en) pharmaceutical formulation, method of treatment and / or prevention of restenosis and kit for the treatment and / or prevention of restenosis
BR112014030949A2 (en) "composition, process for the cosmetic treatment and use of a composition"
ES2598753T3 (en) Pharmaceutical composition for the treatment of calcified tendinitis and / or calcified bursitis
AR097116A1 (en) ALUMINUM CHLORHYDRATE SALTS WITH AN ELEVATED 3 PEAK IN SEC CHROMATOGRAPHY
ES2482441A1 (en) Use of L-carnitine in dermatological cosmetic products for the treatment of stretch marks and scars
CY1118117T1 (en) NEW AMINO-PYRROLINE PRODUCTS AND THEIR USE IN PREVENTION OR TREATMENT OF METABOLIC SYNDROME
BR112015014082A2 (en) use of aluminum salts
ES2721003T3 (en) Use of 1,3-propane disulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis
MX2015016553A (en) Cosmetic or dermatological compositions combining retinaldehyde and glycylglycine oleamide, and the cosmetic or dermatological uses thereof.
IN2013MU02576A (en)
AR095890A1 (en) USE OF TRIFLUOROACETIC ACID AND SALTS OF THE SAME TO TREAT HYPERCHOLESTEROLEMIA

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2482441

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20150331